Toshiaki Tojo
President chez Kitasato Daiichi Sankyo Vaccine Co., Ltd.
Provenance du réseau au premier degré de Toshiaki Tojo
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 35 | |
Kitasato Daiichi Sankyo Vaccine Co., Ltd.
 Kitasato Daiichi Sankyo Vaccine Co., Ltd. Pharmaceuticals: MajorHealth Technology Part of Daiichi Sankyo Co., Ltd., Kitasato Daiichi Sankyo Vaccine Co., Ltd. develops, manufactures and distributes vaccines. The private company is based in Kitamoto, Japan. Kitasato Daiichi Sankyo Vaccine Co. was acquired by Daiichi Sankyo Co., Ltd. from The Kitasato Institute on November 30, 2017.
1
| Subsidiary | Pharmaceuticals: Major | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Toshiaki Tojo via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| QUEST DIAGNOSTICS INCORPORATED | Services to the Health Industry | Corporate Officer/Principal | |
| SONY GROUP CORPORATION | Computer Processing Hardware | Director/Board Member | |
The Robert Wood Johnson Foundation
 The Robert Wood Johnson Foundation Investment Trusts/Mutual FundsMiscellaneous The Robert Wood Johnson Foundation (RWJF) is an independent philanthropic organization headquartered in Princeton, New Jersey. The firm was founded in 1972 and is dedicated solely to health. RWJF funds a wide array of programs which are working to help build a national Culture of Health. | Investment Trusts/Mutual Funds | Corporate Officer/Principal | |
Sumitomo Life Insurance Co.
 Sumitomo Life Insurance Co. Life/Health InsuranceFinance Sumitomo Life Insurance Co. engages in the provision of life insurance services. It also sells investment trust and manages defined contribution pension plans. The company was founded in May 1907 and is headquartered in Osaka, Japan. | Life/Health Insurance | Director/Board Member | |
Sankyo Pharma GmbH
 Sankyo Pharma GmbH Medical DistributorsDistribution Services Part of Daiichi Sankyo Co., Ltd., Sankyo Pharma GmbH is a German pharmaceutical distribution company. The private company is based in Munich, Germany. Jan van Ruymbeke has been the CEO of the company since 2012. | Medical Distributors | Chairman | |
| REATA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Medocity, Inc.
 Medocity, Inc. Medical/Nursing ServicesHealth Services Medocity, Inc. develops a care platform that bridges the gap between the clinic and the patient?s home. It offers a patient-centric mobile solution that combines key aspects of disease-specific care into a platform that can be used on application and Web-based devices. The firm platform also tracks key symptoms and side effects in real time; displays reports and graphic summaries to understand the patient?s health status on a daily basis. The company is headquartered in Parsippany, NJ. | Medical/Nursing Services | Director/Board Member | |
| SUMITOMO MITSUI FINANCIAL GROUP, INC. | Major Banks | President | |
| AJINOMOTO CO., INC. | Food: Specialty/Candy | Director/Board Member | |
| NSK LTD | Auto Parts: OEM | Director/Board Member | |
| FUJIMORI KOGYO CO., LTD. | Industrial Specialties | Director/Board Member | |
| MEI PHARMA, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Keio University | College/University | Undergraduate Degree Corporate Officer/Principal Corporate Officer/Principal | |
| Osaka University | College/University | Graduate Degree | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin | |
| Stony Brook University | College/University | Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree | |
| University of California San Diego | College/University | Undergraduate Degree | |
| University of Connecticut | College/University | Corporate Officer/Principal | |
| University of San Diego | College/University | Masters Business Admin | |
| University of Hitotsubashi | College/University | Undergraduate Degree | |
| University of Tokyo | College/University | Graduate Degree Graduate Degree Graduate Degree Undergraduate Degree Undergraduate Degree | |
| JAPAN POST HOLDINGS CO., LTD. | Life/Health Insurance | President Director/Board Member | |
| Albert Einstein College of Medicine, Inc. | College/University | Doctorate Degree | |
| Tokyo Medical & Dental University | College/University | Doctorate Degree | |
| The Society of Japanese Aerospace Companies | Chairman | ||
| IOVANCE BIOTHERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Financial Accounting Standards Foundation | Chairman | ||
| JAPAN EXCHANGE GROUP, INC. | Investment Banks/Brokers | Director/Board Member | |
| ADC THERAPEUTICS SA | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Compliance Officer | |
| CELCUITY INC. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
| Japan Ship Exporters' Association | Chairman | ||
| Japan Vocational Ability Development Association | Chairman | ||
Taiho Oncology, Inc.
 Taiho Oncology, Inc. Pharmaceuticals: MajorHealth Technology Taiho Oncology, Inc. develops and markets anti-metabolite cancer drugs. It focuses on cornerstone anti-metabolites as well as on targeted small molecule inhibitors. The firm engages in the research, development, and manufacturing of pharmaceutical products in the fields of oncology, allergy and immunology, and urology. It also offers nutrient tonic and crude drug gastrointestinal remedy products. The company was founded in 2002 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Compliance Officer | |
| The Japan Medical Library Association | Chairman | ||
| SOLID BIOSCIENCES INC. | Biotechnology | Director/Board Member | |
Neurogene, Inc.
 Neurogene, Inc. BiotechnologyHealth Technology Neurogene, Inc. focuses on developing disease modifying therapeutics for severe neurologic diseases. Its pipeline includes multiple gene therapy products for ultra-rare diseases, as well as a novel technology that has the potential for use in monogenic autism spectrum disorders and indications not well suited for gene therapy. The company was founded by Rachel McMinn in January 2018 and is headquartered in New York, NY. | Biotechnology | Director/Board Member | |
Wyeth Pharmaceuticals, Inc.
 Wyeth Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. The private company is based in Hartford. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PYXIS ONCOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
St. Luke's SRL Advanced Clinical Research Center, Inc.
 St. Luke's SRL Advanced Clinical Research Center, Inc. Miscellaneous Commercial ServicesCommercial Services St. Luke's SRL Advanced Clinical Research Center, Inc. engages in specimen inspection, research support for clinical examinations, surveys, research and examinations related to treatment and prevention of disease and information provision activities. The company was founded on April 3, 2017 and is headquartered in Tokyo, Japan. | Miscellaneous Commercial Services | Director/Board Member | |
| TAYSHA GENE THERAPIES, INC. | Biotechnology | President | |
SalioGen Therapeutics, Inc.
 SalioGen Therapeutics, Inc. BiotechnologyHealth Technology SalioGen Therapeutics, Inc. is a genetic medicine company based in Cambridge, MA. The company is advancing the Exact DNA Integration Technology (EDIT) platform, which is a mammal-derived genome engineering technology for use in potentially curative non-viral gene therapy. SalioGen Therapeutics has launched Gene Coding, a genetic medicine technology, to develop durable, broadly applicable genetic medicines using its EDIT platform. The company's mission is to transform the treatment paradigm for patients with inherited disorders. Jason F. Cole has been the CEO of the company since 2023. | Biotechnology | Director/Board Member | |
Jaguar Gene Therapy LLC
 Jaguar Gene Therapy LLC Medical/Nursing ServicesHealth Services Jaguar Gene Therapy LLC is a company that aims to accelerate breakthroughs in gene therapy for patients suffering from severe genetic diseases. The company is based in Lake Forest, IL. The company's unrelenting commitment is to advocate boldly and care fiercely for patients and families. The company works together to confront the challenges of treating complex diseases and are advancing their initial pipeline that targets diseases with significant unmet need in sizeable patient populations. Joseph Nolan has been the CEO of the company since 2020. | Medical/Nursing Services | Chief Tech/Sci/R&D Officer | |
| Rutgers Robert Wood Johnson Medical School | College/University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 27 |
| Japon | 21 |
| Royaume-Uni | 2 |
| Allemagne | 2 |
| Inde | 2 |
Sectorielle
| Health Technology | 18 |
| Consumer Services | 14 |
| Finance | 6 |
| Health Services | 4 |
| Electronic Technology | 2 |
Opérationnelle
| Director/Board Member | 89 |
| Corporate Officer/Principal | 37 |
| Independent Dir/Board Member | 27 |
| Chairman | 21 |
| President | 14 |
Relations les plus connectées
| Insiders | |
|---|---|
| Kazuaki Kama | 15 |
| Sukumar Nagendran | 15 |
| Sawako Nohara | 13 |
| Kunio Ishihara | 10 |
| Takashi Okimoto | 10 |
| Hiroshi Hirabayashi | 10 |
| Antoine Yver | 9 |
| Tsuguya Fukui | 7 |
| Jay Feingold | 7 |
| Yoshifumi Nishikawa | 6 |
| Susan Romanus | 6 |
| Naoki Adachi | 6 |
| Noritaka Uji | 6 |
| Hiroshi Toda | 6 |
| Joji Nakayama | 5 |
- Bourse
- Insiders
- Toshiaki Tojo
- Connexions Sociétés
